What is One Home for Sites and why are sites so excited about it? Listen in on Melissa Easy and Brad Hightower as they discuss this important new platform from IQVIA Technologies, then learn more at https://bit.ly/4bXvTRY
IQVIA Technologies’ Post
More Relevant Posts
-
Let's connect at SCOPE
B2B Marketing - Driving demand and awareness through creative campaigns, events, sales enablement, thought leadership and PR.
Who is going to SCOPE Europe? IQVIA has several not to miss presentations on patient technology, protocol design and a panel on the Impact of Site Tech Overload. Let's connect at booth #1! Lorenzo Parma, PhD MBA, Raphaëlle Gilg, Chloe Rose PhD, Alison Liddy, Majd Mirza, Stefan Dürr Melissa Mooney
-
-
🚀 Revolutionise your Market Access Strategy with Apodi's Insight SPRINT! 🚀 Discover how our process empowers industry leaders to unlock profound insights through accelerated market research – delivering access to medicines in record time! 💡 Ready to explore a new path forward? Watch the video below or click here to learn more: https://lnkd.in/dTqNrubh
-
Learn how to expand your use of Alcon’s PanOptix and VIVITY IOLs and elevate your patients’ experience. Register now to hear a panel of experts discuss their valuable insights and practical tips. https://bit.ly/4anufJ2
-
-
The Pompe community is coming together to launch a new data initiative to accelerate research and insights into Pompe Disease. Pompe Consortium is partnering with RARE-X, a program of Global Genes, to build a Data Collection Program for our families. 🎉 When you participate in the Pompe Disease Data Collection Initiative, you’ll help advance research and the development of new drugs, devices, and other therapies for Pompe Disease. All data is patient-owned and managed, allowing you to determine how your research-ready information is used, and by whom. We’ll even be able to share data trends with you. Join us for the data collection platform launch during the Pompe.Community Open Meeting to hear more about the initiative, how the data will be used, and learn how to register to begin sharing information about your experiences. Pompe.Community Open Meeting: Wednesday, June 26th at 3pm PT, 6pm ET! Register on Zoom: https://lnkd.in/e3YRAfME #PompeDisease #PompeCommunity #RareDisease #RareDiseaseResearch #RareX #GlobalGenes
-
The eConsent market is evolving, focusing on improving patient experiences, streamlining clinical trial processes, and global expansion. Staying informed on industry developments is crucial. Join Vinita Navadgi and myself on Tuesday, Nov 12th at 11 am EST for this informative session! #IQVIA #eConsent
Discover eConsent market trajectory, explore IQVIA Complete Consent's cost-effective tailored solutions for all sponsors and study types and get an exclusive look at new features, capabilities, and much more! Register now: https://bit.ly/4fG4cPU
-
-
Recently, the NF Patients United Magazine interviewed our Vice President, Gilles Atlan. This interview covers important topics like how NF2 BioSolutions was started, our latest updates, the goals of our organization, and much more. Click here to read this insightful interview: https://buff.ly/48Nt2cs
-
-
Vox.Bio listens to the customer to reveal the insights that lead to the best decision-making. Visit our site to discover how we make your connections seamless, and your outcomes aligned with what matters most. https://vox.bio/ #CHR #voxbio #healthcareresearch #marketresearch
-
Mama x3 | Vice President of Clinical Operations| Site Operations Enthusiast | Elevate Clinical Research |
🚀 Exciting News! 🚀 Are you a site looking to supercharge your efficiency with data entry and query resolution? Look no further—let’s chat today and make it happen! 💪📈 Don’t miss out on the chance to 【ｅｌｅｖａｔｅ】your site’s performance. Reach out now! 🌟 Elevate Clinical Research #EfficiencyBoost #DataEntry #QueryResolution #its2024
🌟 New Case Study 🌟 🔗: https://bit.ly/3B9j9Lh We're excited to share our new case study highlighting how Elevate Clinical Research revolutionized their site operations by leveraging CRIO's eSource technology. This case study dives into how Elevate utilized global resources to streamline EDC entry and query resolution. By embracing this approach, Elevate saw improved site performance and operational efficiency, setting a new standard for clinical research networks.
-
-
Discover how incorporating real-world data (#RWD) into protocol feasibility, site selection, and patient identification processes results in better, more efficient trial design in our recent blog. https://ow.ly/GoOL50TG63z
Clinical Trial Optimization: Key Strategies for Protocol Feasibility and Site Selection - TriNetX
https://trinetx.com
-
Gen, wishing you a successful Scope2024. For those attending, I would strongly recommend you visit Gen and the team to see how these tools can shape your clinical trial strategy and radically reduce development costs. Great to see AI reflecting Actual Intelligence!
Phesi Booth #1021 is now open at #SCOPE2024! With global data from 100+ million patients, we provide #patientcentric solutions to support our clients in investigator site selection and protocol design optimization in #clinicaldevelopment and #clinicaltrials.
-
